Thalassemia Clinical Trials in Nanning, Guangxi
4 recruitingNanning, Guangxi, China
Showing 1–4 of 4 trials
Recruiting
Phase 1
A Multiple Ascending Dose Study of 9MW3011 in Patients With Non-transfusion-dependent β-thalassemia
Beta-Thalassemia
Mabwell (Shanghai) Bioscience Co., Ltd.40 enrolled2 locationsNCT06772766
Recruiting
Phase 2
Evaluation of Recombinant Humanized Anti-CD25 Monoclonal Antibody for Preventing Graft-versus-host Disease After Haploidentical/matched Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Transfusion-dependent Thalassemia
Transfusion Dependent Thalassemia
Rongrong Liu396 enrolled5 locationsNCT06657391
Recruiting
Early Phase 1
Safety and Efficacy of RM-004 Cells for Hemoglobin H-Constant Spring Disease
Hereditary DiseasesHemoglobinopathiesAlpha Thalassemia Hemoglobin H Constant Spring
The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army5 enrolled1 locationNCT06107400
Recruiting
Early Phase 1
A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia [TDT]
Transfusion Dependent Beta-Thalassemia
First Affiliated Hospital of Guangxi Medical University5 enrolled1 locationNCT05762510